Poly Medicure Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
May 09, 2023 at 12:57 pm IST
Share
Poly Medicure Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 3,068.53 million compared to INR 2,575.16 million a year ago. Revenue was INR 3,153.47 million compared to INR 2,657.13 million a year ago. Net income was INR 588.11 million compared to INR 361.66 million a year ago. Basic earnings per share from continuing operations was INR 6.13 compared to INR 3.77 a year ago. Diluted earnings per share from continuing operations was INR 6.13 compared to INR 3.77 a year ago.
For the full year, sales was INR 11,152.3 million compared to INR 9,230.63 million a year ago. Revenue was INR 11,514.16 million compared to INR 9,609.65 million a year ago. Net income was INR 1,792.83 million compared to INR 1,465.06 million a year ago. Basic earnings per share from continuing operations was INR 18.69 compared to INR 15.28 a year ago. Diluted earnings per share from continuing operations was INR 18.67 compared to INR 15.27 a year ago.
Poly Medicure Limited is an India-based medical devices company. The Company is engaged in manufacturing and selling medical devices. The Company holds a portfolio of over 375 patents covering a range of products in various areas, including vascular access, renal care, transfusion and diagnostics systems. These products cater to a range of therapeutic segments, such as infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It supplies its products to more than 100 countries across Europe, Africa, the Americas, Australia, and Asia. Its products include IV cannula, arterial cannula, prefilled syringe, nasogastric feeding tube, gastro-duodenal feeding tube, umbilical catheter, irrigation sets, urine drainage catheters and others. It operates ten manufacturing facilities across India, China, Egypt and Italy.